SBIR-STTR Award

Developing Software for Pharmacodynamics and Bioassay Studies
Award last edited on: 7/27/2020

Sponsored Program
STTR
Awarding Agency
DOD : DHA
Total Award Amount
$649,934
Award Phase
2
Solicitation Topic Code
DHP16C-001
Principal Investigator
Hua Liang

Company Information

Tconnex Inc

7926 Jones Branch Drive Suite 560
Mclean, VA 22102
   (703) 910-3400
   info@tconnex.com
   www.tconnex.com

Research Institution

George Washington University

Phase I

Contract Number: W81XWH-17-C-0153
Start Date: 9/11/2017    Completed: 4/10/2018
Phase I year
2017
Phase I Amount
$149,935
Estimation of the primary parameters like IC 50 in traditional dose-response modelsmay fail or lead to misleading results when the observations are non-onotonic due to drugresistance or virus mutation in various biomedical lab research. The objective of this project isto develop a novel approach to assess dose response relationship, which is applicable to generalpharmacologic, toxicologic, or other biomedical studies that exhibit a non-monotonic dose-response relationship, and to develop inference tools. User-friendly software, that can handleboth monotonic and non-monotonic dose-response relationships, will be developed and availableto the scientific community.

Phase II

Contract Number: W81XWH18C0152
Start Date: 10/1/2018    Completed: 2/23/2021
Phase II year
2019
Phase II Amount
$499,999
Thegoal is to develop asoftwaretool that implementsa novelapproach applicableto fitgeneral pharmacologic, toxicology, or other biomedical data, that mayexhibita non-monotonic dose-responserelationship for which thecurrent parametricmodels fail. Thesoftwareexplores dose-responserelationships using both monotonicand non-monotonicmodels,and estimates theassociated doseresponsecurves,which can further be used to obtain various important parameters such as IC50, EC50, ED50,LD50, Km, Vmax,and AUC. The tool can be used for hormesis doseresponsecurves. In toxicology, hormesis isaspecial doseresponsefeaturecharacterized by low dose stimulation and high doseinhibition.Furthermore, thetool can model U-shaped doseresponserelationships frequently observed in toxicologyand epidemiology studies